Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries.
Andrea ScottiSara BaggioMatteo PagnesiMarco BarbantiMarianna AdamoAmnon EitanRodrigo Estévez-LoureiroVerena VeulemansStefan ToggweilerDarren MylotteFrederico DeMarcoFrancesco GianniniMarco FerliniChristoph K NaberAndrea BuonoJoachim SchoferWolfgang RottbauerNicolas M D A van MieghemSaib KhogaliMaurizio TaramassoThomas PilgrimJan-Malte SinningDavid ZweikerMatteo MontorfanoJan A S Van der HeydenSalvatore BrugalettaAlfonso IelasiChristian W HammMaarten VanhaverbekeGiuliano CostaMauro MassussiRobert AlarcónTobias ZeusMattia LunardiLuca TestaLuca Di IennoGiuseppe LanzilloAlexander WolfDiego MaffeoFrancesca ZivielloMatteo SaccocciStephan WindeckerAlexander SedaghatAlbrecht SchmidtJorn BrouwerAnder RegueiroBernhard ReimersWon Keun KimLars SondergaardAntonio ColomboAntonio MangieriAzeem Latibnull nullPublished in: Circulation. Cardiovascular interventions (2023)
TAVR with Evolut PRO/PRO+ self-expanding valve is safe and effective. Despite the treatment of heavier calcified anatomies, procedural outcomes are improving over time with less need for pacemaker implantation and less significant paravalvular leaks.